A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer: results from Cancer and Leukemia Group B Study 90006.

Source:http://linkedlifedata.com/resource/pubmed/id/20862750

Cancer 2011 Feb 1 117 3 526-33

Download in:

View as

Triples

General Info

PMID
20862750